DAIKEN MEDICAL CO.,LTD.

7775 TSE Technology Precision Instruments
TSE Standard
¥424.00
+0.00%
Delayed · cached 15 min

Fair value analysis

7775
DAIKEN MEDICAL CO.,LTD.
TechnologyPrecision Instruments
¥424.00
Close used for this calculation
¥368.45Fair value
Financial DNA Score
Profitability · Returns · Balance Sheet · Efficiency · Growth
66/100
Profitability11/25
Returns14/25
Balance Sheet21/25
Efficiency20/25
Growth6/25
Strong
Quality radar
66Prof.11/25Ret.14/25Eff.20/25B.Sht21/25Growth6/25

Consensus fair value

¥368.45
Near FV
▼ -13.1% against the close used
Model range ¥85.12 – ¥642.40
The lowest and highest of the models that produced a value. This is the spread of the methods, not a price target.

Price target range & 52-week position

Bear¥85.12Fair value¥368.45Bull¥642.40
FairClose
52-week traded range
52W low ¥414.0052W high ¥486.00

The 52-week range is measured from the stored price history, not estimated.

Valuation summary

Trading above the consensus fair value

DAIKEN MEDICAL CO.,LTD. closed at ¥424.00, 15.1% above the consensus fair value of ¥368.45 drawn from 9 valuation models.

Financial DNA score 66/100 — Strong. P/E of 13.2x against the 20x sector multiple the P/E model uses.

Quantitative summary only — not investment advice.

All valuation models

DCF Valuation
¥115.15
-72.8%
Σ[CF×(1+g)^n/(1.10)^n] + TV/(1.10)^10
g=2.7%, r=10%, tg=3%, n=10yr
Graham Number
¥441.79
+4.2%
√(22.5 × EPS × BVPS)
EPS=32.12, BVPS=270.06
P/E Fair Value
¥642.40
+51.5%
EPS × 20x (sector P/E)
EPS=32.12, Sector P/E=20x
Peter Lynch (PEG)
¥85.12
-79.9%
EPS × Growth% (PEG = 1 is fair)
EPS=32.12, g=2.7%
EV/EBITDA
¥544.17
+28.3%
(EBITDA × 11.3x − Net Debt) ÷ Shares
EBITDA=1.54B
Dividend Discount (DDM)
¥279.50
-34.1%
D1 ÷ (r − g) where D1 = D0×(1+g)
D0=20.01, r=10%, g=2.7%
Book Value (P/B)
¥351.08
-17.2%
BVPS × (ROE−g)÷(r−g) [Justified P/B — RIM-based]
BVPS=270.06, ROE=12.1%, g=3%, r=10%
Reverse DCF
¥424.00
+0.0%
Solve for g: Price = Σ[EPS×(1+g)^n/(1.10)^n] + TV
Implied: 1.5% | Historical: 2.7%
Margin of Safety
¥299.84
-29.3%
Avg(DCF, Graham, P/E) × 75% (25% safety buffer)
Avg fair value=399.78, MoS=25%

Computed on September 12, 2026 from the most recent annual report on file and that day's closing price. Where a company has seen its earnings move sharply since its last annual report, this figure will lag the market.

Educational data only. Not a recommendation to buy, sell or hold any security.

Educational data only. Not a recommendation to buy, sell or hold any security.